title: Consequences of chronic inflammation in peritoneal dialysis.
abstract: The mortality of end-stage renal disease (ESRD) patients, including those receiving long-term peritoneal dialysis (PD), has remained unacceptably high owing to the prevalence of cardiovascular disease. It is well recognized that both traditional Framingham risk factors and kidney disease-related risk factors may contribute to the high prevalence of cardiovascular disease in these patients. Of the different risk factors, chronic inflammation frequently is observed in long-term PD patients. The causes of inflammation are usually complex and multifactorial, involving both dialysis-related and dialysis-unrelated factors. Inflammation is strongly associated with cardiovascular disease and malnutrition, and has been shown consistently to be a powerful predictor of mortality and adverse cardiovascular outcomes in PD patients. In this article we review the prevalence and potential causes of chronic inflammation in PD patients. More importantly, we provide emerging evidence that shows the serious consequences of chronic systemic inflammation in PD patients and the important contribution of inflammation to adverse clinical outcomes.
authors: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong. aymwang@hku.hk
authors: Angela Yee-Moon
authors: AY
authors: Wang
mesh_terms: D002097:C-Reactive Protein / Q000032:analysis; D002100:Cachexia / Q000209:etiology; D002114:Calcinosis / Q000209:etiology; D006332:Cardiomegaly / Q000209:etiology; D002908:Chronic Disease; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D007249:Inflammation / Q000150:complications* / Q000453:epidemiology / Q000209:etiology; D007333:Insulin Resistance; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D053244:Osteoprotegerin / Q000502:physiology; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D015995:Prevalence
chemical_list: D053244:Osteoprotegerin; D002097:C-Reactive Protein